Interleukin-18 Inhibition in Inflammatory Bowel Disease: A Delicate Balance

Inflamm Bowel Dis. 2024 Apr 3;30(4):693-694. doi: 10.1093/ibd/izae042.

Authors

Sem Geertsema¹, Raphael R Fagundes², Antonius T Otten¹, Gerard Dijkstra¹, Klaas Nico Faber¹, Arno R Bourgonje^{1

3}

Affiliations

¹ Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
² Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands.
³ Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

PMID: 38442894
DOI: 10.1093/ibd/izae042

No abstract available

Publication types

Editorial
Comment

MeSH terms

Animals
Antibodies, Monoclonal
Colitis*
Inflammatory Bowel Diseases* / immunology
Interleukin-18
Mice

Substances

Antibodies, Monoclonal
Interleukin-18